Advertisement
AFIPA vs PUK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFIPA is a Hold and PUK is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFIPA’s FA Score shows that 0 FA rating(s) are green whilePUK’s FA Score has 0 green FA rating(s).
- AFIPA’s FA Score: 0 green, 5 red.
- PUK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PUK’s TA Score shows that 3 TA indicator(s) are bullish.
- PUK’s TA Score: 3 bullish, 5 bearish.
Price Growth
AFIPA (@Life/Health Insurance) experienced а 0.00% price change this week, while PUK (@Life/Health Insurance) price change was -2.32% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -1.41%. For the same industry, the average monthly price growth was +3.56%, and the average quarterly price growth was +4.09%.
Reported Earning Dates
PUK is expected to report earnings on Mar 26, 2025.
Industries' Descriptions
@Life/Health Insurance (-1.41% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| AFIPA | PUK | AFIPA / PUK | |
| Capitalization | N/A | 25.8B | - |
| EBITDA | N/A | N/A | - |
| Gain YTD | 0.000 | 44.812 | - |
| P/E Ratio | N/A | 15.34 | - |
| Revenue | N/A | 12B | - |
| Total Cash | N/A | N/A | - |
| Total Debt | N/A | 4.87B | - |
AFIPA | PUK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 45 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 96 | |
PRICE GROWTH RATING 1..100 | 69 | 39 | |
P/E GROWTH RATING 1..100 | 100 | 69 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AFIPA's Valuation (46) in the null industry is in the same range as PUK (76) in the Multi Line Insurance industry. This means that AFIPA’s stock grew similarly to PUK’s over the last 12 months.
AFIPA's Profit vs Risk Rating (100) in the null industry is in the same range as PUK (100) in the Multi Line Insurance industry. This means that AFIPA’s stock grew similarly to PUK’s over the last 12 months.
PUK's SMR Rating (96) in the Multi Line Insurance industry is in the same range as AFIPA (100) in the null industry. This means that PUK’s stock grew similarly to AFIPA’s over the last 12 months.
PUK's Price Growth Rating (39) in the Multi Line Insurance industry is in the same range as AFIPA (69) in the null industry. This means that PUK’s stock grew similarly to AFIPA’s over the last 12 months.
PUK's P/E Growth Rating (69) in the Multi Line Insurance industry is in the same range as AFIPA (100) in the null industry. This means that PUK’s stock grew similarly to AFIPA’s over the last 12 months.
| PUK | |
|---|---|
| RSI ODDS (%) | 2 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 74% |
| Momentum ODDS (%) | 3 days ago 50% |
| MACD ODDS (%) | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 54% |
| Advances ODDS (%) | 11 days ago 60% |
| Declines ODDS (%) | 2 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 61% |
Advertisement
AFIPA and
Correlation & Price change
A.I.dvisor tells us that AFIPA and ABL have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AFIPA and ABL's prices will move in lockstep.
| Ticker / NAME | Correlation To AFIPA | 1D Price Change % | ||
|---|---|---|---|---|
| AFIPA | 100% | N/A | ||
| ABL - AFIPA | 12% Poorly correlated | -2.73% | ||
| CILJF - AFIPA | 11% Poorly correlated | -0.74% | ||
| FG - AFIPA | 6% Poorly correlated | N/A | ||
| PUK - AFIPA | 6% Poorly correlated | N/A | ||
| AAGIY - AFIPA | 5% Poorly correlated | +0.12% | ||
More | ||||